Camargo
FEBRUARY 10, 2021
The results of the population analysis reveal the average relative bioavailability of the test to reference. The comparison of relative bioavailability based on simulated data then indicates if BE can be achieved. Pharmacokinetics Scientist. Co-Authors: Galina Bernstein, PhD. Senior Director, Clinical Pharmacology. Pop-Pharm.
Pharmaceutical Technology
APRIL 20, 2023
In the first phase of its training workshops, the Pharmaceutical Innovation Center plans to develop a range of excipients [inactive substances that serve as the vehicle or medium for a drug or other active substance] for controlled release dosage forms, improving their bioavailability, along with formulating orally dispersible and chewable tablets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MARCH 16, 2021
Antiverse – which was co-founded in 2017 by engineers Murat Tunaboylu and Ben Holland – says it will use the cash injection to build a new laboratory in Cardiff and expand its technical team through recruitment of specialist machine learning engineers, laboratory scientists and structural biologists.
Pharmaceutical Technology
JANUARY 25, 2023
Syngene has more than seven years of experience with 450+ scientists working in targeted protein modulator (degraders and stabilizers) class, both in chemistry and biology under different collaborative projects. Syngene’s PROTAC capabilities put it at the forefront of developing novel protein degraders across a range of diseases.
Camargo
DECEMBER 22, 2021
Clinical pharmacology may also involve comparative bioavailability analyses, which are generally required for drug formulation bridging studies, to demonstrate bioequivalence. Scientist, Regulatory Strategy. Biowaiver Eligibility. These capabilities help sponsors to operate within the relevant regulatory framework to meet their goals.
Pharmaceutical Technology
AUGUST 3, 2022
The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development. The discovery of a new chemical entity (NCE) that could potentially lead the way to a ground-breaking therapeutic treatment is an exciting prospect for any chemist.
Cloudbyz
MARCH 5, 2024
Oral Bioavailability: Developing small molecules that are effectively absorbed when administered orally, while also being stable in the digestive system, can be complex. Enhancing bioavailability is often a key focus in the development of small molecule drugs.
Expert insights. Personalized for you.
133 
Let's personalize your content